Diabetes and obesity - Issue 44/2022
Reviews
74
91
New therapeutic indications for SGLT2 inhibitors
Zbynek Schroner
95
Effect of intensive lifestyle modification in patients with obesity (even extreme obesity) on cardiometabolic parameters
Adela Penesová, Jana Babjaková, Viktor Bielik, Žofia Rádiková, Libuša Kubáňová
Clinical studies
109
MAFLD screening in real practice in Slovakia: the SIRIUS study
Mária Szántová, Tomáš Koller, Marek Rác, Svetlana Adamcová-Selčanová, Xénia Faktorová, Martina Jakabovičová, Zuzana Urkovičová, Viliam Mojto, Peter Jarčuška, Martin Janíčko, Ubomír Skladaný
News
129
Diabetes and obesity
2022 Issue 44
Most read in this issue
- MAFLD screening in real practice in Slovakia: the SIRIUS study
- Finerenone – a new option to reduce the risk of progression of renal and cardiovascular damage in patients with chronic kidney disease and type 2 diabetes mellitus
- New therapeutic indications for SGLT2 inhibitors
- Effect of intensive lifestyle modification in patients with obesity (even extreme obesity) on cardiometabolic parameters